NRSN

NeuroSense Therapeutics Ltd.

HealthcareBiotechnologyILUSDPeers →Country macro →

$0.80

LiveJun 18, 2026

Market cap

$19.85M

52w range

0.63 – 2.35

P / E

—

EPS

—

Volume

241.04K

Revenue · FY

—

Explain this page

Arphra AIPlain-English read on NeuroSense Therapeutics Ltd.’s valuation

Enterprise value

$19.85M

Market cap

$19.85M

Net debt

—

Total debt

—

Cash & ST inv.

—

Capital structure

· balance sheet · 2026-06-20

Market capitalisation$19.85M

+ Total debt+—

− Cash & short-term investments−—

= Enterprise value$19.85M

Valuation

· key metrics · TTM

EV / EBITDA-3.1×

EV / Sales0.0×

EV / FCF-9925.4×

Net debt / EBITDA-0.0×

Debt / Equity—

Arphra AIPlain-English read on the EV build & leverage